Perspectives for diagnostic and treatment in alcoholic encephalopathy at early disease stage

101 patients with alcoholic encephalopathy, aged from 30 to 60 years, were enrolled in the study. Patients were divided into three groups: 34 patients in the treatment group received neiromidin in a dose of 15 mg in solution during 10 days and then in tabs in a dose of 20 mg three times a day during...

Full description

Saved in:
Bibliographic Details
Published inUchenye zapiski (Sankt-Peterburgskiĭ gosudarstvennyĭ medit͡s︡inskiĭ universitet im. akad. I.P. Pavlova) Vol. 22; no. 4; pp. 83 - 86
Main Authors Barantsevich, E. R., Kurashevich, K. G.
Format Journal Article
LanguageEnglish
Russian
Published Academician I.P. Pavlov First St. Petersburg State Medical University 30.12.2015
Subjects
alcoholic encephalopathy
metadoxil
neiromidin
алкогольная энцефалопатия
метадоксил
нейромидин
Online AccessGet full text

Cover

More Information
Summary:101 patients with alcoholic encephalopathy, aged from 30 to 60 years, were enrolled in the study. Patients were divided into three groups: 34 patients in the treatment group received neiromidin in a dose of 15 mg in solution during 10 days and then in tabs in a dose of 20 mg three times a day during 2 months; 32 patients in the treatment group received vasoactive, antioxidant treatment and metadoxil in a dose of 500 mg three times a day during 2 months. The comparison group included 35 patients receiving only vasoactive and antioxidant treatment. To the end of treatment, the positive changes in the state of patients reflected in the decrease in the number of complaints and neurological symptoms were seen in the treatment groups.
ISSN:1607-4181
2541-8807
DOI:10.24884/1607-4181-2015-22-4-83-86